ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Veterinary Immunology and Immunopathology
Volume 68, Issues 2-4, May 1999, Pages 209-227
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (1136 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/S0165-2427(99)00024-0    How to Cite or Link Using DOI (Opens New Window)
Copyright © 1999 Elsevier Science B.V. All rights reserved

Tilapia (Oreochromis niloticus) dosed with azathioprine display immune effects similar to those seen in mammals, including apoptosis

R. M. Gogal Jr.*, B. J. Smith, J. L. Robertson, S. A. Smith and S. D. Holladay

Center for Molecular Medicine and Infectious Diseases, Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, 1410 Prices Fork Road, Blacksburg, VA 24061, USA

Accepted 8 February 1999.
Available online 2 June 1999.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Azathioprine, an anti-neoplastic drug and therapeutic immunosuppressant, was administered intraperitoneally at 10.0 and 50.0 mg/kg to 3–6-month-old tilapia (Oreochromis niloticus). Consistent alterations in immune cellular parameters of the blood, pronephros (hematopoietic kidney) and spleen were observed. Peripheral blood total cellularity decreased as the azathioprine dose increased, to approximately half that of the control. Differential analysis of white blood cells indicated a decline in lymphocyte number, in particular, with increased dosage of azathioprine. Pronephric total cellularity was depressed in fish receiving the 10.0 or 50.0 mg/kg dose. In contrast, both splenic weight and splenic total cellularity increased proportionately with the increase in the drug dosage. Histopathologic examination of the spleens showed normal patterns for both control and 10.0 mg/kg dose groups. At 50.0 mg/kg, spleens were characterized by marked expansion of the white pulp, although lymphocytes were rare. Melanomacrophage centers at the higher dose were also larger and more numerous than in the control group. Evaluation of splenic and pronephric leukocytes with apoptotic markers showed an increase in apoptotic cells in the pronephros with increasing drug dose. These changes in fish are consistent with those seen in humans and laboratory rodents dosed with azathioprine, suggesting that fish may be potentially useful as preliminary models for detecting immunosuppressive compounds.

Author Keywords: Immunotoxicity; Fish; Apoptosis; Azathioprine; In vitro; Tilapia

Index Terms: immunosuppressive treatment; azathioprine

Article Outline

1. Introduction
2. Materials and methods
2.1. Fish
2.2. Chemical preparation and exposure
2.3. Blood collection/ euthanasia
2.4. Blood analysis
2.4.1. Total blood cellularity
2.4.2. Blood differential counts
2.5. Spleen collection and analysis
2.6. Pronephros collection and analysis
2.7. Leukocyte isolation and cyto-centrifugation
2.8. Flow cytometric evaluation of pronephric and splenic leukocytes for apoptosis
2.9. Leukocyte proliferation assay
2.10. Mixed lymphocyte reaction assay (MLR)
2.11. Histopatholgy of the spleen and pronephros
2.12. Statistical analysis
3. Results
3.1. Blood total cellularity and peripheral blood lymphocytes
3.2. Splenic total cellularity and spleen weight to body weight ratios
3.3. Pronephric total cellularity
3.4. Cyto-centrifugation of spleen and pronephros
3.5. Verification of apoptotic cells using flow cytometry and 7- AAD
3.6. Leukocyte proliferation and mixed lymphocyte reaction assays
3.7. Histopathology of spleen and pronephros
4. Discussion
Acknowledgements
References









 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.